MiLaboratories and Miltenyi Biotec Announce Strategic Partnership to Advance Next Generation Therapies

SAN FRANCISCO–(BUSINESS WIRE)–MiLaboratories, a leader in RNA immune technologies, and Miltenyi Biotec, a global pioneer in biotechnology, are excited to announce a landmark partnership that promises to revolutionize the field of next-generation therapies. This collaboration combines MiLaboratories’ cutting-edge RNA kit technology for immune sequencing with Miltenyi Biotec’s robust production and commercialization capabilities. Under this agreement, MiLaboratories will grant exclusive rights
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks